We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

2 hedge funds and large institutions have $3.92K invested in Calithera Biosciences, Inc in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% less funds holding

Funds holding: 23 → 2 (-21)

100% less capital invested

Capital invested by funds: $5.01M → $3.92K (-$5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

Holders
2
Holders Change
-21
Holders Change %
-91.3%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.52M
2
Primecap Management
Primecap Management
California
-$1.31M
3
Citadel Advisors
Citadel Advisors
Florida
-$650K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$505K
5
BlackRock
BlackRock
New York
-$273K
Name Holding Trade Value Shares
Change 		Change in
Stake
FCA
1
FinTrust Capital Advisors
South Carolina
$3.92K – – –
BI
2
BVF Inc
California
– -$1.52M -464,742 Closed
Primecap Management
3
Primecap Management
California
– -$1.31M -401,080 Closed
Citadel Advisors
4
Citadel Advisors
Florida
– -$650K -199,269 Closed
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
– -$505K -155,070 Closed
BlackRock
6
BlackRock
New York
– -$273K -83,839 Closed
Renaissance Technologies
7
Renaissance Technologies
New York
– -$218K -66,795 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$154K -47,169 Closed
TCMG
9
TSP Capital Management Group
New Jersey
– -$146K -44,750 Closed
Geode Capital Management
10
Geode Capital Management
Massachusetts
– -$95K -29,176 Closed
JP Morgan Chase
11
JP Morgan Chase
New York
– -$79K -24,345 Closed
State Street
12
State Street
Massachusetts
– -$35.2K -10,805 Closed
Wells Fargo
13
Wells Fargo
California
– -$12.3K -3,782 Closed
Morgan Stanley
14
Morgan Stanley
New York
– -$2.27K -697 Closed
CAS
15
Coppell Advisory Solutions
Texas
– -$2.2K -675 Closed
CASC
16
Coppell Advisory Solutions Corp
Texas
– -$2.2K -675 Closed
Group One Trading
17
Group One Trading
Illinois
– -$2.15K -660 Closed
Bank of America
18
Bank of America
North Carolina
– -$1.76K -539 Closed
UBS Group
19
UBS Group
Switzerland
– -$1.05K -321 Closed
ACP
20
Arcus Capital Partners
Georgia
– -$815 -250 Closed
TC
21
Truvestments Capital
Florida
– -$170 -52 Closed
Citigroup
22
Citigroup
New York
– -$46 -14 Closed

CALA Hedge Fund Activity: Q1 2023 in Review

2 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2023, worth a combined $3.92K — down 100% from $5.01M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CALA and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $1.52M sold.

  • 2 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2023, down from 23 in Q4 2022.
  • Funds reported $3.92K of Calithera Biosciences, Inc stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Calithera Biosciences, Inc positions in Q1 2023 and 21 closed out, a net change of -21 holders.
  • The largest Calithera Biosciences, Inc seller in Q1 2023 was BVF Inc, an estimated $1.52M sold.

Based on aggregated 13F filings for Q1 2023.